RGC
NASDAQ HealthcareRegencell Bioscience Holdings Limited - Ordinary Shares
Drug Manufacturers - Specialty & Generic
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
๐ Market Data
| Price | $5.35 |
|---|---|
| Volume | 184,009 |
| Market Cap | 2.65B |
| Beta | 1.490 |
| RSI (14-Day) | 37.8 |
| 200-Day MA | $20.50 |
| 50-Day MA | $8.52 |
| 52-Week High | $69.00 |
| 52-Week Low | $4.51 |
| Price / Book | 2675.00 |
๐ฏ Investment Strategy Scores
RGC scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (99/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ฐ Dividend Daddy (14/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find RGC in your text
Paste any article, transcript, or post โ the tool will extract RGC and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.